These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 9733875)

  • 41. Tissue specificity of the Kaposi's sarcoma-associated herpesvirus latent nuclear antigen (LANA/orf73) promoter in transgenic mice.
    Jeong JH; Hines-Boykin R; Ash JD; Dittmer DP
    J Virol; 2002 Nov; 76(21):11024-32. PubMed ID: 12368345
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Open reading frame 50 protein of Kaposi's sarcoma-associated herpesvirus directly activates the viral PAN and K12 genes by binding to related response elements.
    Chang PJ; Shedd D; Gradoville L; Cho MS; Chen LW; Chang J; Miller G
    J Virol; 2002 Apr; 76(7):3168-78. PubMed ID: 11884541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma.
    Cesarman E; Nador RG; Bai F; Bohenzky RA; Russo JJ; Moore PS; Chang Y; Knowles DM
    J Virol; 1996 Nov; 70(11):8218-23. PubMed ID: 8892957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures.
    Ciufo DM; Cannon JS; Poole LJ; Wu FY; Murray P; Ambinder RF; Hayward GS
    J Virol; 2001 Jun; 75(12):5614-26. PubMed ID: 11356969
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hot-spot variations of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen and application in genotyping by PCR-RFLP.
    Zhang YJ; Deng JH; Rabkin C; Gao SJ
    J Gen Virol; 2000 Aug; 81(Pt 8):2049-2058. PubMed ID: 10900044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene structure and expression of Kaposi's sarcoma-associated herpesvirus ORF56, ORF57, ORF58, and ORF59.
    Majerciak V; Yamanegi K; Zheng ZM
    J Virol; 2006 Dec; 80(24):11968-81. PubMed ID: 17020939
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transcription activation of polyadenylated nuclear rna by rta in human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus.
    Song MJ; Brown HJ; Wu TT; Sun R
    J Virol; 2001 Apr; 75(7):3129-40. PubMed ID: 11238840
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells.
    Cai X; Lu S; Zhang Z; Gonzalez CM; Damania B; Cullen BR
    Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5570-5. PubMed ID: 15800047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis.
    Ramalingam D; Happel C; Ziegelbauer JM
    J Virol; 2015 Apr; 89(8):4249-61. PubMed ID: 25631082
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification and analysis of the K5 gene of Kaposi's sarcoma-associated herpesvirus.
    Haque M; Chen J; Ueda K; Mori Y; Nakano K; Hirata Y; Kanamori S; Uchiyama Y; Inagi R; Okuno T; Yamanishi K
    J Virol; 2000 Mar; 74(6):2867-75. PubMed ID: 10684303
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of CCAAT/enhancer-binding protein alpha (C/EBPalpha) in activation of the Kaposi's sarcoma-associated herpesvirus (KSHV) lytic-cycle replication-associated protein (RAP) promoter in cooperation with the KSHV replication and transcription activator (RTA) and RAP.
    Wang SE; Wu FY; Fujimuro M; Zong J; Hayward SD; Hayward GS
    J Virol; 2003 Jan; 77(1):600-23. PubMed ID: 12477864
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathological Features of Kaposi's Sarcoma-Associated Herpesvirus Infection.
    Katano H
    Adv Exp Med Biol; 2018; 1045():357-376. PubMed ID: 29896675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 ORF57 promoter.
    Duan W; Wang S; Liu S; Wood C
    Arch Virol; 2001; 146(2):403-13. PubMed ID: 11315648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Establishment and maintenance of Kaposi's sarcoma-associated herpesvirus latency in B cells.
    Chen L; Lagunoff M
    J Virol; 2005 Nov; 79(22):14383-91. PubMed ID: 16254372
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma.
    Stürzl M; Blasig C; Schreier A; Neipel F; Hohenadl C; Cornali E; Ascherl G; Esser S; Brockmeyer NH; Ekman M; Kaaya EE; Tschachler E; Biberfeld P
    Int J Cancer; 1997 Jul; 72(1):68-71. PubMed ID: 9212225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication.
    Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M
    J Virol; 2017 May; 91(10):. PubMed ID: 28275189
    [TBL] [Abstract][Full Text] [Related]  

  • 58. KSHV Genome Replication and Maintenance in Latency.
    Ueda K
    Adv Exp Med Biol; 2018; 1045():299-320. PubMed ID: 29896673
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
    Renne R; Barry C; Dittmer D; Compitello N; Brown PO; Ganem D
    J Virol; 2001 Jan; 75(1):458-68. PubMed ID: 11119614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53.
    Rivas C; Thlick AE; Parravicini C; Moore PS; Chang Y
    J Virol; 2001 Jan; 75(1):429-38. PubMed ID: 11119611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.